Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Nature Communications Open Access 12 February 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Cancer–neuronal crosstalk and the startups working to silence it. Nat Biotechnol 38, 115–117 (2020). https://doi.org/10.1038/s41587-020-0411-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0411-9
This article is cited by
-
Krebsneurowissenschaft
Der Nervenarzt (2022)
-
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Nature Communications (2021)